GOLDSTEIN DOV A MD

CIK 000112047810 companiesBETHESDA, MD

SEC Profile

Transactions

Companies

Filings

CIK

0001120478

Recent Transactions

50 trades

Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2026-07-15+25,000→ 25,000 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Common Stock
2026-04-23$4.38/sh+3,542→ 36,575 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-04-23−3,542→ 155,833 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-03-01−3,542→ 159,375 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Common Stock
2026-03-01$4.38/sh+3,542→ 33,033 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-02-17+110,000→ 110,000 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Common Stock
2026-02-01$4.38/sh+3,541→ 29,491 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-02-01−3,541→ 162,917 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-16$4.38/sh+3,542→ 25,950 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-01-16−3,542→ 166,458 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$19.45/sh−4,440→ 35,994 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2026-01-13−27,000→ 92,587 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$20.54/sh−11,663→ 24,331 total
Exercise/Conversion
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$8.39/sh+27,000→ 49,408 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$18.43/sh−8,974→ 40,434 total
Sale
BioAge Labs, Inc.$BIOA
Common Stock
2026-01-13$21.08/sh−1,923→ 22,408 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2026-01-02+10,000→ 10,000 total
Exercise/Conversion
Coya Therapeutics, Inc.$COYA
Common Stock, par value $0.0001 per share
2025-08-18$1.09/sh+17,557→ 27,557 total
Exercise/Conversion
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2025-08-18−17,557→ 0 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2025-06-24+15,000→ 15,000 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2025-02-25+5,000→ 5,000 total
Award
BioAge Labs, Inc.$BIOA
Stock Option (Right to Buy)
2025-02-18+170,000→ 170,000 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2025-01-01+5,000→ 5,000 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2024-06-24+15,000→ 15,000 total
Award
Coya Therapeutics, Inc.$COYA
Stock Option (right to buy)
2024-01-01+5,000→ 5,000 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2023-06-23+10,500→ 10,500 total
Purchase
Coya Therapeutics, Inc.$COYA
Warrant to Purchase Common Stock
2023-01-03+5,000→ 5,000 total
Purchase
Coya Therapeutics, Inc.$COYA
Common Stock, par value $0.0001 per share
2023-01-03+10,000→ 10,000 total
Award
Gain Therapeutics, Inc.$GANX
Stock Option (right to buy)
2022-09-20+10,500→ 10,500 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2022-09-09+37,600→ 37,600 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2021-08-19+38,135→ 38,135 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2021-06-18$4.75/sh+8,000→ 30,000 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2021-04-26$5.00/sh+12,000→ 22,000 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2020-09-09+14,634→ 14,634 total
Purchase
NeuBase Therapeutics, Inc.
Common Stock
2020-04-30$6.00/sh+10,000→ 10,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Employee Stock Option (right to buy)
2020-02-28+15,000→ 15,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2020-02-28+7,500→ 7,500 total
Award
ADMA BIOLOGICS, INC.$ADMA
Common Stock
2020-02-28+7,500→ 7,500 total
Award
NeuBase Therapeutics, Inc.
Stock option (right to buy)
2019-07-12+227,330→ 227,330 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2019-03-13+30,000→ 30,000 total
Award
ADMA BIOLOGICS, INC.$ADMA
Stock Option (right to buy)
2018-06-22+17,500→ 17,500 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2018-06-06+8,000→ 0 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2018-06-06+5,000→ 0 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06−8,000→ 47 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06−5,000→ 8,047 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06$17.75/sh+8,000→ 13,047 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Common Stock
2018-06-06$14.42/sh+5,000→ 5,047 total
Award
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2018-05-23+10,100→ 10,100 total
Exercise/Conversion
Esperion Therapeutics, Inc.$ESPR
Stock Option (right to buy)
2017-12-18−21,471→ 0 total
Other
Esperion Therapeutics, Inc.$ESPR
Common Stock
2017-12-18−21,471→ 47 total

GOLDSTEIN DOV A MD

Recent Transactions

Companies

Recent Filings

Address